CIBC Asset Management Inc boosted its stake in Express Scripts Holding (NASDAQ:ESRX) by 4.3% in the fourth quarter, HoldingsChannel.com reports. The firm owned 78,226 shares of the company’s stock after acquiring an additional 3,221 shares during the quarter. CIBC Asset Management Inc’s holdings in Express Scripts were worth $5,839,000 at the end of the most recent quarter.

A number of other institutional investors also recently added to or reduced their stakes in the stock. Stonebridge Capital Advisors LLC grew its holdings in Express Scripts by 0.4% in the second quarter. Stonebridge Capital Advisors LLC now owns 24,059 shares of the company’s stock valued at $1,536,000 after purchasing an additional 100 shares during the period. National Asset Management Inc. grew its holdings in Express Scripts by 1.5% in the second quarter. National Asset Management Inc. now owns 7,939 shares of the company’s stock valued at $510,000 after purchasing an additional 115 shares during the period. San Francisco Sentry Investment Group CA grew its stake in Express Scripts by 3.2% during the second quarter. San Francisco Sentry Investment Group CA now owns 4,487 shares of the company’s stock worth $286,000 after buying an additional 138 shares during the period. Ironwood Investment Counsel LLC grew its stake in Express Scripts by 2.7% during the second quarter. Ironwood Investment Counsel LLC now owns 5,327 shares of the company’s stock worth $340,000 after buying an additional 140 shares during the period. Finally, L & S Advisors Inc grew its stake in Express Scripts by 2.3% during the second quarter. L & S Advisors Inc now owns 6,140 shares of the company’s stock worth $392,000 after buying an additional 140 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

In other news, VP Glen D. Stettin sold 3,449 shares of the business’s stock in a transaction on Thursday, January 11th. The shares were sold at an average price of $81.00, for a total transaction of $279,369.00. Following the transaction, the vice president now directly owns 33,715 shares of the company’s stock, valued at $2,730,915. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, VP Glen D. Stettin sold 3,448 shares of the business’s stock in a transaction on Tuesday, January 2nd. The stock was sold at an average price of $76.00, for a total transaction of $262,048.00. The disclosure for this sale can be found here. Over the last three months, insiders have sold 17,001 shares of company stock worth $1,249,505. Corporate insiders own 0.68% of the company’s stock.

Express Scripts Holding (NASDAQ ESRX) opened at $74.50 on Tuesday. Express Scripts Holding has a 12-month low of $55.80 and a 12-month high of $83.49. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.61 and a current ratio of 0.73. The company has a market cap of $43,327.54, a price-to-earnings ratio of 11.18, a PEG ratio of 0.85 and a beta of 0.93.

Express Scripts declared that its board has approved a share repurchase program on Monday, December 18th that permits the company to buyback 45,000,000 outstanding shares. This buyback authorization permits the company to repurchase shares of its stock through open market purchases. Shares buyback programs are usually an indication that the company’s management believes its stock is undervalued.

Several equities research analysts have issued reports on ESRX shares. Maxim Group boosted their price objective on shares of Express Scripts from $78.00 to $87.00 and gave the stock a “buy” rating in a research note on Thursday, December 14th. Raymond James Financial reiterated an “underperform” rating on shares of Express Scripts in a research note on Monday, October 9th. Deutsche Bank started coverage on shares of Express Scripts in a research note on Monday, December 4th. They set a “buy” rating and a $75.00 price objective for the company. Zacks Investment Research downgraded shares of Express Scripts from a “buy” rating to a “sell” rating in a research note on Tuesday, October 24th. Finally, Royal Bank of Canada set a $66.00 price objective on shares of Express Scripts and gave the stock a “hold” rating in a research note on Wednesday, October 25th. Six research analysts have rated the stock with a sell rating, eight have given a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company’s stock. Express Scripts has a consensus rating of “Hold” and an average target price of $78.23.

WARNING: “Express Scripts Holding (ESRX) Position Raised by CIBC Asset Management Inc” was originally posted by Watch List News and is owned by of Watch List News. If you are accessing this piece on another publication, it was stolen and republished in violation of United States & international trademark and copyright laws. The correct version of this piece can be read at https://www.watchlistnews.com/express-scripts-holding-esrx-position-raised-by-cibc-asset-management-inc/1847630.html.

Express Scripts Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.